Penn Center for Myeloproliferative Neoplasms

Daria V. Babushok

faculty photo

Daria V. Babushok

Instructor A of Medicine
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
West Pavilion, 2nd Floor
3400 Civic Center Blvd
Philadelphia, PA
Office: 215-662-3933
Fax: 215-615-5887
Education:
BA (Biology, Chemistry)
Bryn Mawr College, 2000.
PhD (Cellular and Molecular Biology)
University of Pennsylvania, 2007.
MD (Medicine)
University of Pennsylvania, 2008.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Bone marrow failure syndromes, myeloproliferative neoplasms

Description of Research Expertise

Genetics of acquired bone marrow failure syndromes, hematopoiesis, acquired aplastic anemia

Selected Publications

Aynardi J, Manur R, Hess PR, Chekol S, Morrissette JJD, Babushok D, Hexner E, Rogers HJ, Hsi ED, Margolskee E, Orazi A, Hasserjian R, Bagg A.: JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group. Br J Haematol. May 16 2018 Notes: doi: 10.1111/bjh.15276. [Epub ahead of print]

Soderquist CR, Ewalt MD, Czuchlewski DR, Geyer JT, Rogers HJ, Hsi ED, Wang SA, Bueso-Ramos CE, Orazi A, Arber DA, Hexner EO, Babushok DV, Bagg A. : Myeloproliferative Neoplasms with Concurrent BCR-ABL1 Translocation and JAK2 V617F Mutation: a Multi-institutional Study from the Bone Marrow Pathology Group. Mod Pathol 31(5): 690-704, May 2018.

Babushok D, Bessler M. : Aplastic Anemia and Pure Red Cell Aplasia. Chapter 18. In Anemia: Pathophysiology, Diagnosis and Management. Cambridge University Press. Edward J. Benz, Nancy Berliner and Fred J. Schiffman. (eds.). Apr 30 2018 Notes: ISBN-10: 0521514266.

Sarthy J, Zha J, Babushok D, Shenoy A, Fan J-M, Wertheim G, Himebach A, Munchel A, Taraseviciute A, Yang S, Shima H, Narumi S, Meshinchi S, Olson TS. : Poor Outcome with Hematopoietic Stem Cell Transplantation for Bone Marrow Failure and MDS with Severe MIRAGE Syndrome Phenotype. Blood Adv 2(2): 120-125, Jan 23 2018.

Peslak SA, Olson TS, Babushok DV. : Diagnosis and Treatment of Aplastic Anemia, Current Treatment Options in Oncology, Curr Treat Options Oncol 18(12): 70, Nov 16 2017.

Babushok DV, Duke JL, Xie HM, Stanley N, Atienza J, Perdigones, N, Nicholas P, Ferriola D, Li Y, Huang H, Ye W, Morrissette J, Podsakoff G, Biegel JA, Chou S, Monos DS, Bessler M, Olson TS.: Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications. Blood Adv 1(22): 1900-1910, Oct 10 2017.

Reilly CR, Babushok DV, Martin K, Spivak JL, Streiff M, Bahirwani R, Mondschein J, Stein B, Moliterno A, Hexner EO. : Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension. Am J Hematol 92(9): 909-914, Sep 2017.

Babushok DV, Duke JL, Xie HM, Stanley N, Atienza J, Perdigones, N., Nicholas, P., Ferriola D, Li, Y., Huang, H., Wenda Y, Morrissette, J., Podsakoff, G., Biegel JA, Chou, S., Monos DS, Bessler M, Olson TS. : Immunoediting Through Somatic Loss of HLA Class I Alleles Uncovers the Role of HLA Class I-Mediated Autoimmunity in Acquired Aplastic Anemia. Federation of Clinical Immunology Societies Annual Meeting, Chicago, IL. Jun 2017 Notes: "Poster Presentation"

Babushok DV, Duke JL, Xie HM, Stanley N, Atienza J, Perdigones, N., Nicholas, P., Ferriola D, Li, Y., Huang, H., Wenda Y, Morrissette, J., Podsakoff, G., Biegel JA, Chou, S., Monos DS, Bessler M, Olson TS. : Addition by Subtraction: Clonal Hematopoiesis as a Reflection of Pathophysiology of Acquired Aplastic Anemia. Heme Malignancy Research in Progress Meeting. University of Pennsylvania, Philadelphia, PA Jun 5 2017 Notes: "Oral Presentation"

Stanley NS, Olson TS, Babushok, DV.: Recent advances in understanding clonal haematopoiesis in aplastic anaemia. Br J Haematol 177(4): 509-525, May 2017.

back to top
Last updated: 05/23/2018
The Trustees of the University of Pennsylvania
 

The Penn Difference

  • Individualized Treatment Plan
  • Expert Treatment Team Knowledgeable in Myeloproliferative Disorders
  • State-of-the-Art Personalized Diagnostic Testing
  • Access to Newest Therapies Through Clinical Trials
  • Comprehensive Bone Marrow Transplantation Service
  • Integrated Care by a Multidisciplinary Treatment Team

Make an Appointment

New Patients:
Abramson Cancer Center
Perelman Center for Advanced Medicine
2nd Floor, West Pavilion
Philadelphia, PA 19104
Phone: 215-615-5858 option 2
Fax: 215-615-5889

Current Patients:
Contact your doctor directly

For General Inquiries:
Call the Myeloproliferative Neoplasms Program at  215-614-1847


Donate


Search